Your browser doesn't support javascript.
loading
Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced.
Sethi, S K; Rohatgi, S; Dragon-Durey, M A; Raghunathan, V; Dhaliwal, M; Rawat, A; Jha, P; Bansal, S B; Raina, R; Kher, V.
  • Sethi SK; Department of Nephrology, Kidney and Urology Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Rohatgi S; Department of Nephrology, Kidney and Urology Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Dragon-Durey MA; INSERM UMRS 1138, Team 10 and Paris Descartes University, Paris, France.
  • Raghunathan V; Pediatric Intensive Care, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Dhaliwal M; Pediatric Intensive Care, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Rawat A; Department of Nephrology, Kidney and Urology Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Jha P; Department of Nephrology, Kidney and Urology Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Bansal SB; Department of Nephrology, Kidney and Urology Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
  • Raina R; Department of Pediatric Nephrology, Akron Children's Hospital, Cleveland, Ohio, USA.
  • Kher V; Department of Nephrology, Kidney and Urology Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
Indian J Nephrol ; 27(1): 58-61, 2017.
Article en En | MEDLINE | ID: mdl-28182046